← All trials
NCT04095572
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 27, 2020
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Sep 19, 2019
- Last posted
- Nov 2, 2021
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of BaselLead sponsor
- IBSA Institut Biochimique SACollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.